Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Heart plaque Dx co gets $17m

This article was originally published in Clinica

Executive Summary

Burlington, Massachusetts-based InfraReDx has raised $17m in new capital to initiate commercialisation of its near-infrared, catheter-based diagnostics system for detecting arterial plaque. The financing round, the company's third to date, was led by Sanderling Ventures and included the participation of new and existing individual investors, according to VentureWire. InfraReDx is expecting its technology to help prevent a second heart attack in patients who have already suffered a coronary event. The company is planning a limited roll-out of the system pending FDA approval, which is expected this quarter.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT046401

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel